Nilsine Partners’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.48M Buy
34,434
+1,596
+5% +$165K 0.24% 92
2026
Q1
$3.31M Buy
32,838
+2,574
+9% +$264K 0.26% 90
2025
Q4
$3.21M Buy
30,264
+1,884
+7% +$218K 0.28% 79
2025
Q3
$3.6M Buy
28,380
+724
+3% +$86.2K 0.32% 66
2025
Q2
$3.39M Buy
27,656
+230
+0.8% +$26.3K 0.34% 69
2025
Q1
$2.78M Buy
+27,426
New +$2.68M 0.3% 81

Other funds holding EHC

Nilsine Partners's EHC Position: Q2 2026 in Review

Nilsine Partners increased its Encompass Health (EHC) stake by 4.9% in Q2 2026, buying an estimated $165K and bringing the position to 34,434 shares worth $3.48M. The position accounts for 0.24% of the portfolio, ranked #92.

Nilsine Partners first reported a position in EHC in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.6M in Q3 2025. 599 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Nilsine Partners held 34,434 shares of Encompass Health worth $3.48M as of Q2 2026.
  • Nilsine Partners bought 1,596 Encompass Health shares in Q2 2026, an estimated $165K.
  • Encompass Health made up 0.24% of Nilsine Partners's portfolio in Q2 2026, its #92 holding.
  • Nilsine Partners first reported a position in Encompass Health in Q1 2025 and has held it in 6 quarters since.
  • Nilsine Partners's Encompass Health position peaked at $3.6M in Q3 2025.
  • 599 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Nilsine Partners's 13F filing for Q2 2026, filed 24 Jul 2026.